Zura Bio (ZURA) Profit After Tax (2022 - 2026)

Zura Bio's Profit After Tax history runs 5 years deep, the most recent figure standing at -$24.2 million for Q1 2026.

• On a quarterly basis, Profit After Tax fell 38.88% year-over-year to -$24.2 million in Q1 2026; TTM through Mar 2026 was -$75.4 million, a 21.43% decrease from a year earlier, with the FY2025 full-year figure at -$68.6 million, down 31.0% from the prior year.
• Profit After Tax slipped to -$24.2 million in Q1 2026 per ZURA's latest filing, from -$17.2 million in the prior quarter.
• Across five years, Profit After Tax topped out at $7.8 million in Q1 2022 and bottomed at -$34.0 million in Q2 2023.
• The 5-year median for Profit After Tax is -$13.6 million (2024), against an average of -$12.7 million.
• Across the five-year window, Profit After Tax plunged 3578.38% in 2023 and soared 69.64% in 2024, its largest moves.
• Year by year, Profit After Tax stood at -$15.9 million in 2022, then surged by 45.41% to -$8.7 million in 2023, then plunged by 57.04% to -$13.6 million in 2024, then declined by 25.87% to -$17.2 million in 2025, then tumbled by 41.24% to -$24.2 million in 2026.
• Per Business Quant, the three latest ZURA Profit After Tax figures stand at -$24.2 million (Q1 2026), -$17.2 million (Q4 2025), and -$18.0 million (Q3 2025).